Cantor Fitzgerald reissued their overweight rating on shares of Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. The firm currently has a $35.00 price objective on the stock, up from their previous price objective of $16.00. Cantor Fitzgerald also issued estimates for Longboard Pharmaceuticals’ FY2023 […]
Longboard Pharmaceuticals (NASDAQ:LBPH) Stock Rating Reaffirmed by Wedbush kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 569,600 shares, a decline of 10.1% from the August 31st total of 633,900 shares. Approximately 3.1% of the shares of the company are […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) has received an average rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have issued a report on the stock in […]
Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) have been given a consensus recommendation of “Buy” by the six brokerages that are covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock […]